NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Bibiana Bielekova
National Institute of Allergy and Infectious Diseases - Maryland / United States
Others
AD Scientific Index ID: 4392011
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Bibiana Bielekova's MOST POPULAR ARTICLES
1-)
Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapyRA Morgan, N Chinnasamy, D Abate-Daga, A Gros, PF Robbins, Z Zheng, ...Journal of immunotherapy 36 (2), 133-151, 201311222013
2-)
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligandB Bielekova, B Goodwin, N Richert, I Cortese, T Kondo, G Afshar, B Gran, ...Nature medicine 6 (10), 1167-1175, 20009522000
3-)
Regulatory CD56bright natural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosisB Bielekova, M Catalfamo, S Reichert-Scrivner, A Packer, M Cerna, ...Proceedings of the National Academy of Sciences 103 (15), 5941-5946, 20066852006
4-)
Development of biomarkers in multiple sclerosisB Bielekova, R MartinBrain 127 (7), 1463-1478, 20044112004
5-)
Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon βB Bielekova, N Richert, T Howard, G Blevins, S Markovic-Plese, ...Proceedings of the National Academy of Sciences 101 (23), 8705-8708, 20043982004
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept